PubRank

A Frilling

Author PubWeight™ 48.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994 2.14
2 Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. J Mol Med (Berl) 1997 1.77
3 Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 1994 1.51
4 Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 1997 1.31
5 Liver resection of colorectal metastases in elderly patients. Br J Surg 2010 1.21
6 Management of concomitant hepatic artery injury in patients with iatrogenic major bile duct injury after laparoscopic cholecystectomy. Br J Surg 2008 1.18
7 Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res 1990 1.16
8 Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer 1995 1.10
9 Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 1995 1.05
10 Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000 1.00
11 Preoperative volume prediction in adult living donor liver transplantation: how much can we rely on it? Am J Transplant 2007 0.97
12 Surgical reintervention for differentiated thyroid cancer. Br J Surg 1993 0.96
13 Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease. World J Surg 2014 0.95
14 Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1998 0.95
15 Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Eur J Med Res 2005 0.94
16 Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) 1995 0.92
17 Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res 1996 0.92
18 Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. J Intern Med 1995 0.91
19 [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006 0.91
20 Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab 1996 0.90
21 Multiple endocrine neoplasia type 1 (MEN 1) revisited. Virchows Arch 1995 0.90
22 Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol 2003 0.88
23 Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 1996 0.87
24 Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring. Aliment Pharmacol Ther 2007 0.86
25 Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy. Eur Surg Res 2007 0.85
26 Timing and risk factors of hepatectomy in the management of complications following laparoscopic cholecystectomy. J Gastrointest Surg 2011 0.85
27 Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 2008 0.84
28 Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. Transplant Proc 2004 0.84
29 Successful sealing of benign esophageal leaks after temporary placement of a self-expanding plastic stent without fluoroscopic guidance. Z Gastroenterol 2006 0.83
30 Cancer of unknown primary. Recent Results Cancer Res 2008 0.82
31 Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes 2000 0.82
32 Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria. Eur J Med Res 2006 0.82
33 Living donor liver transplantation. HPB (Oxford) 2006 0.82
34 Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease). Transplantation 2001 0.82
35 Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma. Nuklearmedizin 2005 0.82
36 [Two cystic retroperitoneal lesions mimicking adrenal cysts]. Pathologe 2005 0.81
37 Increased major histocompatibility complex (MHC) expression in nontoxic goiters is associated with iodide depletion, enhanced ability of the follicular thyroglobulin to increase MHC gene expression, and thyroid autoantibodies. J Clin Endocrinol Metab 2000 0.80
38 Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study. Transplant Proc 2004 0.79
39 [Early operation as a treatment measure in thyrotoxic crisis]. Chirurg 2001 0.79
40 Gallbladder endometriosis as a cause of occult bleeding. World J Gastroenterol 2007 0.78
41 CNI-sparing regimens within the liver transplant setting: experiences of a single center. Clin Transpl 2004 0.78
42 Recurrent intestinal bleeding of obscure origin after biliary drainage procedures in pancreatic disease. Eur J Surg 1994 0.78
43 [Multiple endocrine neoplasia type 1 (MEN 1). Molecular genetics, morphology and prognosis]. Pathologe 1994 0.78
44 [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system]. Langenbecks Arch Chir Suppl Kongressbd 1998 0.77
45 No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma. Langenbecks Arch Surg 1999 0.77
46 Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection. Transplant Proc 2003 0.77
47 Telomerase activity in neuroendocrine tumors. Int J Surg Investig 2000 0.77
48 Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer. Eur J Ultrasound 2003 0.76
49 Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors. J Clin Endocrinol Metab 1997 0.76
50 [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate]. Dtsch Med Wochenschr 2001 0.76
51 [Preventive total thyroidectomy in children with MEN-2A syndrome]. Chirurg 1994 0.75
52 [Living donor liver transplantation]. Chirurg 2008 0.75
53 [Living organ donor transplantation--the German experience in comparison to others]. Chirurg 2003 0.75
54 Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis: results and ethical issues. Eur Surg Res 2007 0.75
55 Telomerase activity in benign and malignant adrenal tumors. Exp Clin Endocrinol Diabetes 1999 0.75
56 [New techniques in liver transplantation]. Praxis (Bern 1994) 2005 0.75
57 [Continously increasing sensitivity in thyroid cancer aftercare in the course of three generations of thyroglobulin IMAs]. Nuklearmedizin 2003 0.75
58 [Liver transplantation in elderly patients]. Urologe A 2004 0.75
59 Thyroid-stimulating antibodies of Graves' disease in thyroid cancer. N Engl J Med 1988 0.75
60 [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control]. Rofo 2006 0.75
61 The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 1995 0.75
62 [Sporadic unilateral adrenal medullary hyperplasia--a rare cause of hypertension]. Chirurg 1996 0.75
63 Surgical variabilities in living organ procurement. Transplant Proc 2003 0.75
64 Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression. J Clin Endocrinol Metab 2015 0.75
65 [Recurrence of a renal cell carcinoma mimicking a multiple endocrine neoplasia with thyroid gland involvement]. Nuklearmedizin 2002 0.75
66 [Therapeutic strategy and prognosis of malignant struma]. Zentralbl Chir 1990 0.75
67 [Molecular diagnosis of multiple type 2 endocrine neoplasia]. Vestn Ross Akad Med Nauk 2001 0.75
68 [A registry of medullary thyroid cancer in West Germany]. Med Klin (Munich) 1990 0.75
69 [Hyperplasia and tumors of the parathyroid glands]. Pathologe 2003 0.75
70 [A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions]. Genetika 1998 0.75
71 [Reoperation following correction of partial defects of the endocardial cushion (indication, incidence, results)]. Z Kardiol 1984 0.75
72 [Surgical and interventional treatment of liver metastases]. MMW Fortschr Med 2005 0.75
73 The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2. Henry Ford Hosp Med J 1989 0.75
74 Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients. Eur J Med Res 2006 0.75
75 Are CAT-scans necessary for preoperative localization of insulinomas? Eur J Med 1992 0.75
76 27-bp deletion in the ret proto-oncogene as a somatic mutation associated with medullary thyroid carcinoma. J Mol Med (Berl) 1998 0.75
77 [Surgical therapy of primary and secondary liver tumors]. Praxis (Bern 1994) 1997 0.75
78 Surgery for immunogenic hyperthyroidism. Exp Clin Endocrinol 1991 0.75
79 [Rapid diagnosis of recurrence of a tall cell variant of papillary thyroid cancer by endogenous TSH stimulation]. Nuklearmedizin 2003 0.75
80 [Blood substitution in surgery]. Chirurg 2001 0.75
81 [Various strategies in the diagnosis and therapy of thyroid gland cancer. Results of a survey]. Chirurg 1989 0.75
82 [Primary retroperitoneal tumors]. Dtsch Med Wochenschr 1986 0.75
83 [Morphology and function-based surgery in different forms of hyperthyroidism]. Chirurg 1991 0.75
84 [Intrathoracic struma]. Chirurg 1989 0.75
85 Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome. J Endocrinol Invest 1995 0.75
86 [Indications for and basic principles of the surgical treatment of thyroid diseases]. Radiologe 1989 0.75
87 [Cold struma nodule--an absolute surgical indication?]. Langenbecks Arch Chir 1986 0.75